Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Bluefin Biomedicine, Inc.

Clinical trials sponsored by Bluefin Biomedicine, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New antibody aims to calm eczema Flare-Ups from the inside Results expected Feb 2027 (estimated)
  • New hope for painful skin condition: drug trial targets stubborn HS Results expected Aug 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1 Not yet finished but already full! 1
Sort by
  • New hope for painful skin condition: drug trial targets stubborn HS

    Disease control Recruiting now

    This study tests a new drug called BFB759 for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and abscesses. About 210 adults will receive either BFB759 or a placebo to see if the drug reduces the number of painful bumps an…

    Phase 2/3 • Sponsor: Bluefin Biomedicine, Inc. • Aim: Disease control

    Last updated Jun 27, 2026 13:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space